Distribution of iron oxide core-titanium dioxide shell nanoparticles in VX2 tumor bearing rabbits introduced by two different delivery modalities
- Northwestern Univ., Chicago, IL (United States); Alexandria Univ., Alexandria (Egypt)
- Northwestern Univ., Chicago, IL (United States)
- Alexandria Univ., Alexandria (Egypt)
- Argonne National Lab. (ANL), Argonne, IL (United States)
- Vanderbilt Univ. School of Medicine, Nashville, TN (United States)
This work compares intravenous (IV) versus fluoroscopy-guided transarterial intra-catheter (IC) delivery of iron oxide core-titanium dioxide shell nanoparticles (NPs) in vivo in VX2 model of liver cancer in rabbits. NPs coated with glucose and decorated with a peptide sequence from cortactin were administered to animals with developed VX2 liver cancer. Two hours after NPs delivery tumors, normal liver, kidney, lung and spleen tissues were harvested and used for a series on histological and elemental analysis tests. Quantification of NPs in tissues was done both by bulk inductively coupled plasma mass spectrometry (ICP-MS) analysis and by hard X-ray fluorescence microscopy. Both IV and IC NPs injection are feasible modalities for delivering NPs to VX2 liver tumors with comparable tumor accumulation. It is possible that this is an outcome of the fact that VX2 tumors are highly vascularized and hemorrhagic, and therefore enhanced permeability and retention (EPR) plays the most significant role in accumulation of nanoparticles in tumor tissue. It is, however, interesting to note that IV delivery led to increased sequestration of NPs by spleen and normal liver tissue, while IC delivery lead to more NP positive Kupffer cells. Furthermore, this difference is most likely a direct outcome of blood flow dynamics. Armed with this knowledge about nanoparticle delivery, we plan to test them as radiosensitizers in the future.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH); U.S. Army Research Laboratory, U.S. Army Research Office (ARO)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1341018
- Journal Information:
- Nanomaterials, Vol. 6, Issue 8; ISSN 2079-4991
- Publisher:
- MDPICopyright Statement
- Country of Publication:
- United States
- Language:
- English
Web of Science
MRI-guided interventional natural killer cell delivery for liver tumor treatment
|
journal | March 2018 |
Similar Records
Changes in Hepatic Blood Flow During Transcatheter Arterial Infusion with Heated Saline in Hepatic VX2 Tumor
Interferometric phase-contrast X-ray CT imaging of VX2 rabbit cancer at 35keV X-ray energy